Concepedia

Stephen Lake

SL

41

Publications

8.5K

Citations

31

H-Index

2000

Active since

Affiliations

Brigham and Women's Hospital(Current)

Harvard University

University of Cambridge

University of California, Los Angeles

Queen Mary University of London

Stephen Lake is an author at Brigham and Women's Hospital specializing in medicine, genetic epidemiology, and genetics.

ORCID

Top concepts

Publications per year

2000–2021

41

Publications

41

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Jeffrey Cohen, Alasdair Coles, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations

, , +8

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial

Alasdair Coles, Cary Twyman, Douglas L. Arnold et al. · The Lancet · 2012 · 1.2K citations · Full text

, , +4

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) Trial

Philippe Menasché, Ottavio Alfieri, Stefan Janssens et al. · Circulation · 2008 · 938 citations

A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease

Ans T. van der Ploeg, Paula R. Clemens, Deyanira Corzo et al. · New England Journal of Medicine · 2010 · 726 citations · Full text

Estimation and Tests of Haplotype-Environment Interaction when Linkage Phase Is Ambiguous

Stephen Lake, Helen N. Lyon, Kelan G. Tantisira et al. · Human Heredity · 2003 · 434 citations

, , +19

Rows per page

1–5 of 41